Status:

COMPLETED

Living Well With Serious Illness "Wicokuje Sica Tuha Akisniya Wiconi": Wawokiya Health Advocate Intervention

Lead Sponsor:

Massachusetts General Hospital

Collaborating Sponsors:

South Dakota State University

Avera McKennan Hospital & University Health Center

Conditions:

Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Informed by a Community Advisory Board (CAB) and community assessments performed in the first phase of work funded through R01CA240080, this study will test a wawokiya (one who helps) health advocate ...

Detailed Description

One of the greatest areas of need in cancer care for American Indians in the Northern Plains is palliative care.Defined as the services needed to live well with serious illness, access to palliative c...

Eligibility Criteria

Inclusion

  • Patients
  • Age greater than or equal to 18 years old
  • Carry an active invasive cancer diagnosis (other than non-melanoma skin cancer)
  • Self-report as a member of a federally recognized tribe
  • Reside on Pine Ridge, Rosebud, or Cheyenne River Indian Reservations or within the Contract Health Service Delivery Area of the Pine Ridge, Cheyenne River, or Rosebud IHS Service Unit
  • Able to complete baseline surveys
  • Able to provide informed consent
  • A clinician responds "no" to the question: "Would it be a surprise if this person died in the next 12 months?"

Exclusion

  • Do not meet any of the above criteria
  • Caregivers
  • Inclusion Criteria:
  • Are greater than or equal to 18 years old
  • Reside in Pine Ridge, Rosebud, or Cheyenne River Indian Reservations or within the Contract Health Service Delivery Area of the Pine Ridge, Cheyenne River, or Rosebud IHS Service Unit
  • Identified as caregiver by an enrolled patient;
  • Caregiver will be defined as anyone who patients identify as a consistent source of physical, mental, emotional or spiritual support.
  • Able to complete baseline survey
  • Able to provide informed consent

Key Trial Info

Start Date :

February 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2024

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT05208606

Start Date

February 1 2023

End Date

December 31 2024

Last Update

May 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Walking Forward - Avera Research Institute

Rapid City, South Dakota, United States, 57701